Home > Products > Featured products

Meptazinol (hydrochloride)

  Cat. No.:  DC9526   Featured
Chemical Structure
59263-76-2
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Meptazinol Hcl(WY-22811 Hcl) is a unique centrally active opioid analgesic.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 59263-76-2
Chemical Name: Meptazinol hydrochloride
Synonyms: Meptazinol hydrochloride;3-(3-Ethylhexahydro-1-methyl-1H-azepin-3-yl)phenol hydrochloride;Meptazinol HCl;Meptazinol Hydrochlo;3-(3-ethyl-1-methylazepan-3-yl)phenol,hydrochloride;IL-22811 hydrochloride;WY-22811 hydrochloride;3-(3-ethylhexahydro-1-methyl-1H-azepin-3-yl)-phenol hydrochloride;Meptazinol (hydrochloride);Meptazinol hydrochloride [USAN];IL 22811;WY 22811;3-(3-ethyl-1-methylazepan-3-yl)phenol hydrochloride;m-(3-Ethyl-1-methyl-hexahydro-1H-azepin-3-yl)phenol hydrochloride;m-(3-Ethylhexahydro-1-methyl-1H-azepin-3-yl)phenol hydrochlo
SMILES: Cl.CCC1(CN(C)CCCC1)C2=CC(O)=CC=C2
Formula: C15H24ClNO
M.Wt: 269.8102
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Meptazinol Hcl(WY-22811 Hcl) is a unique centrally active opioid analgesic.
In Vivo: in vivo: Given at equianalgesic doses, morphine (3.5 mg/kg i.v.) significantly lowers the pO2 over 20 mm Hg and raises the pCO2 over 10 mm Hg as measured in arterial blood samples, whereas meptazinol (10 mg/kg i.v.) has no significant effects on either. The group receiving meptazinol demonstrated no cardiovascular changes although bispectral index dropped by an additional 19% when compared to 1 min after barbiturate injection . Rapid and significant levels of MEP in plasma and CSF can be achieved after nasal administration whereas the oral administration resulted in considerably lower drug concentrations.
In Vitro: in vitro: Meptazinol inhibits a portion of 3H-labeled opiate and opioid peptide binding quite potently, with IC50 value under 1 nM.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
2018-0101
Cat. No. Product name Field of application
DC46693 DAMGO DAMGO (DAGO) is a potent and selective μ opioid receptor agonist with ki of 17 nM.
DC44976 LY2940094 tartrate LY2940094 (BTRX-246040) tartrate is a potent, brain penetrant, selective and orally available N/OFQ peptide (NOP) receptor antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). LY2940094 tartrate reduces Ethanol self-administration and Ethanol seeking in animal models.
DC28780 LY2444296 LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ∼1 nM. LY2444296 exhibits anti-anxiety like effects.
DC10290 PZM21 PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM.
DC9527 Methylnaltrexone (Bromide) Methylnaltrexone Bromide is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation.
DC9526 Meptazinol (hydrochloride) Meptazinol Hcl(WY-22811 Hcl) is a unique centrally active opioid analgesic.
DC7050 ADL5859 HCl ADL5859 agonizes δ-opioid receptor with a 1000-fold selectivity than µ- or κ-opioid receptor with Ki of 32 nM and 37 nM, respectively.ADL5859 displays weak inhibitory activity at the hERG channel with an IC50 of 78 μM. The EC50 of ADL5859 against δ opioid
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia